Intelligent Bio Solutions (INBS) Raw Materials (2023 - 2025)
Intelligent Bio Solutions' quarterly Raw Materials came in at $205083.0 in Q2 2025, up 8.69% year-on-year from $188693.0 in Q2 2024, and down 25.03% quarter-over-quarter from $273546.0 in Q1 2025.
Intelligent Bio Solutions has reported Raw Materials for 3 years, with the latest figure at $205083.0 in Q2 2025.
- For the quarter ending Q2 2025, Raw Materials rose 8.69% year-over-year to $205083.0; the trailing twelve-month figure through Jun 2025 stood at $205083.0 (up 8.69% YoY), and the FY2025 full-year result was $205083.0, up 8.69% from the prior year.
- Raw Materials for Q2 2025 stood at $205083.0, down from $273546.0 in the prior quarter.
- The five-year high for Raw Materials was $625771.0 in Q1 2024, with the low at $188693.0 in Q2 2024.
- Average Raw Materials over 3 years is $312025.9, with a median of $252149.0 recorded in 2024.
- Peak annual rise in Raw Materials reached 8.69% in 2025, while the deepest fall reached 56.29% in 2025.
- Tracing INBS's Raw Materials over 3 years: stood at $419889.0 in 2023, then plunged by 39.95% to $252149.0 in 2024, then declined by 18.67% to $205083.0 in 2025.
- The last three Raw Materials figures came in at $205083.0 (Q2 2025), $273546.0 (Q1 2025), and $252149.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 205,083.00 |
| Mar 31, 2025 | 273,546.00 |
| Dec 31, 2024 | 252,149.00 |
| Sep 30, 2024 | 219,050.00 |
| Jun 30, 2024 | 188,693.00 |
| Mar 31, 2024 | 625,771.00 |
| Jun 30, 2023 | 419,889.00 |